We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.40
Bid: 47.50
Ask: 48.10
Change: 0.00 (0.00%)
Spread: 0.60 (1.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and Open Offer and Firm Placing

8 Dec 2009 17:06

RNS Number : 8027D
Renold PLC
08 December 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESAUSTRALIACANADAJAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

Renold plc ("Renold" or the "Company")

Result of Placing and Open Offer and Firm Placing

 

On 17 November 2009, the Board of Directors of Renold announced details of a proposed Placing and Open Offer and Firm Placing to raise approximately £26.9 million (net of expenses) through the issue of  142,500,000 New Ordinary Shares at an Issue Price of 20 pence per New Ordinary Share, with  87,500,000 New Ordinary Shares to be issued through the Placing and Open Offer and 55,000,000 New Ordinary Shares to be issued through the Firm Placing. 

The Open Offer closed for acceptance at 11.00 a.m. on 8 December 2009.  Renold is pleased to announce that it has received valid acceptances under the Open Offer in respect of 56,507,038 Open Offer Shares from Qualifying Shareholders. This represents 64.6 per cent. of the Open Offer Shares offered pursuant to the Open Offer.

Accordingly, the remaining 30,992,962 Open Offer Shares, representing 35.4 per cent. of the Open Offer Shares issued through the Placing and Open Offer, have been allocated to the investors with whom they had been conditionally placed.

The Placing and Open Offer and Firm Placing is conditional upon, amongst other things, the approval of Shareholders at the General Meeting (scheduled for 12.00 noon on 9 December 2009 at the offices of Singer Capital Markets Limited at One Hanover Street, London W1S 1 YZ) and upon Admission. The  142,500,000  New Ordinary Shares are expected to be admitted to listing on the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities with effect from 8.00 a.m. on 10 December 2009. Thereafter Renold will have a total of 219,564,703 New Ordinary Shares issued and outstanding.

Set out below is an expected timetable of principal events in relation to the Placing and Open Offer and Firm Placing.

Event

Time/date

General Meeting

12.00 noon on 9 December 2009

Admission and commencement of dealings in the New Ordinary Shares

8.00 a.m. on 10 December 2009

New Ordinary Shares in uncertificated form expected to be credited to accounts in CREST

8.00 a.m. on 10 December 2009

Despatch of definitive share certificates for the New Ordinary Shares in certificated form

by 17 December 2009

General notes:

1. Reference to times in this announcement are to London time unless otherwise stated.
 
2. The times and/or dates set out in the expected timetable of principal events above and mentioned throughout this announcement may be adjusted by Renold, in which event details of the new times and/or dates will be notified to the UK Listing Authority, the London Stock Exchange and, where appropriate, Qualifying Shareholders. In particular, in the event that withdrawal rights arise under Section 87Q of FSMA prior to Admission, the Company, Singer Capital Markets and Smith & Williamson may agree to defer Admission until such time as such withdrawal rights no longer apply.
 
3. This announcement should be read in conjunction with the full text of the combined circular and prospectus published by Renold and circulated to Shareholders on 17 November 2009 (the “Prospectus”'). A copy of the Prospectus is available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at: The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS. In addition, copies of the Prospectus are available during normal business hours on Monday to Friday of each week (public holidays excepted) from the head office of the Company at Renold House, Styal Road, Wythenshawe, Manchester M22 5WL. In addition the Prospectus is available for inspection up to and including the date of Admission at the offices of Eversheds LLP at 1 Wood Street, London EC2V 7WS and Singer Capital Markets Limited at One Hanover Street, London W1S 1YX. Copies of the Prospectus are also available on the Company's website at www.renold.com.

 

Capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Prospectus. 

For further information, please contact:

Renold plc
0161 498 4500
Robert Davies, Chief Executive
 
Peter Bream, Finance Director
 
 
 
Singer Capital Markets (Financial Adviser and Broker)
0203 205 7500
Shaun Dobson
 
Nicholas How
 
 
 
Smith & Williamson Corporate Finance (Sponsor)
020 7131 4000
Azhic Basirov
 
Siobhan Sergeant
 
 
 
College Hill
020 7457 2020
Mark Garraway
 
 
 

 

Important notice

THIS ANNOUNCEMENT IS AN ADVERTISEMENT. IT IS NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION CONTAINED IN THE PROSPECTUS. THE PROSPECTUS IS AVAILABLE ON RENOLD'S WEBSITE AND AVAILABLE FOR INSPECTION AT THE UK LISTING AUTHORITY'S DOCUMENT VIEWING FACILITY.

Neither the content of Renold's website nor any website accessible by hyperlinks on Renold's website is incorporated in, or forms part of, this announcement.

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United StatesAustraliaCanadaJapan or South Africa or any other jurisdiction into which the same would be unlawful. 

 

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, the New Ordinary Shares or any other securities to any person in Australia, Canada, Japan or South Africa, or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada, JapanSouth Africa or the United States or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, JapanSouth Africa or the United States. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of AustraliaCanadaJapanSouth Africa or the United States. The availability of the Placing and Open Offer and Firm Placing to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any application requirements. 

The New Ordinary Shares have not been and will not be registered under the US Securities Act or under the securities laws of any state or other jurisdiction of the United States or under any securities laws of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States, or within any of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful. There will be no public offer of the New Ordinary Shares in the United States

 

The distribution of this announcement and the offering of the New Ordinary Shares in jurisdictions other than the United Kingdom may be restricted by law. No action has been taken by the Company, Singer Capital Markets or Smith & Williamson that would permit an offering of such shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company, Singer Capital Markets and Smith & Williamson to inform themselves about, and to observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is for information only and does not constitute or form part of any offer or invitation to issue, acquire or dispose of any securities or investment advice in any jurisdiction. 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied is, or will be made as to, or in relation to, and no responsibility or liability is, or will be, accepted by either Singer Capital Markets or Smith & Williamson or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Singer Capital Markets, which is a member of the London Stock Exchange and is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for the Company and no one else in connection with the Placing and Open Offer and Firm Placing and Admission. It will not be responsible to anyone other than the Company for providing the protections afforded to customers of Singer Capital Markets or for advising any other person on the transactions and arrangements referred to herein. No representation or warranty, express or implied, is made by Singer Capital Markets as to any of the contents of this announcement for which the Company and the Directors are solely responsible. Singer Capital Markets has not authorised the contents of, or any part of, this announcement and (without limiting the statutory rights of any person to whom this announcement is issued) no liability whatsoever is accepted by Singer Capital Markets for the accuracy of any information or opinions contained in this announcement or for the omission of any material information, for which the Company and the Directors are solely responsible.

Smith & Williamson, which is a member of the London Stock Exchange and is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for the Company and no one else in connection with the Placing and Open Offer and Firm Placing and Admission. It will not be responsible to anyone other than the Company for providing the protections afforded to customers of Smith & Williamson or for advising any other person on the transactions and arrangements referred to herein. No representation or warranty, express or implied, is made by Smith & Williamson as to any of the contents of this announcement for which the Company and the Directors are solely responsible. Smith & Williamson has not authorised the contents of, or any part of, this announcement and (without limiting the statutory rights of any person to whom this announcement is issued) no liability whatsoever is accepted by Smith & Williamson for the accuracy of any information or opinions contained in this announcement or for the omission of any material information, for which the Company and the Directors are solely responsible.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEAXAPEEFNFFE
Date   Source Headline
15th Apr 20247:00 amRNSTrading update for the year ended 31 March 2024
4th Mar 20241:13 pmRNSHolding(s) in Company
16th Feb 20243:37 pmRNSHolding(s) in Company
5th Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20249:59 amRNSHolding(s) in Company
18th Jan 20243:41 pmRNSHolding(s) in Company
18th Jan 20243:40 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20237:00 amRNSPreference Stock Dividend
20th Nov 20234:20 pmRNSHolding(s) in Company
16th Nov 20234:53 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSInterim Results
3rd Nov 20237:05 amRNSNotice of Results
5th Sep 20234:15 pmRNSResult of AGM
5th Sep 20237:00 amRNSAGM Trading Update
1st Sep 20237:00 amRNSAcquisition of Davidson Chain PTY
7th Aug 20239:00 amRNS2023 Annual Report and Accounts and 2023 AGM
2nd Aug 20232:21 pmRNSHolding(s) in Company
25th Jul 202312:15 pmRNSGrant of Options
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.